Last reviewed · How we verify
NCT06155734
Fluorescence Guided Minimally-Invasive Resection Of Abdominal Paragangliomas Using Indocyanine Green
trial testing Fluorescence guided identification using indocyanine green in Paraganglioma in 6 participants. Status unknown.
30 December 2023
Quick facts
| Lead sponsor | Leiden University Medical Center |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 6 |
| Start date | 11 November 2023 |
| Primary completion | 30 December 2023 |
| Estimated completion | 20 February 2024 |
| Sites | 1 location across Netherlands |
Drugs / interventions tested
- Fluorescence guided identification using indocyanine green — full drug profile →
Conditions studied
- Paraganglioma — all drugs for Paraganglioma →
Sponsor
Leiden University Medical Center
Who can join
18 and older, any sex, with Paraganglioma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is exploring whether it's possible to detect paragangliomas (a rare type of tumor) during minimally invasive surgery by using a technique called near-infrared fluorescence imaging, guided by a substance called indocyanine green (ICG). The goal is to see if this method can help surgeons identify and treat paragangliomas more accurately and during minimally invasive procedures.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Fluorescence-guided minimally-invasive resection of abdominal paragangliomas using indocyanine green.
van Dam MA, Crobach ASLP, Boekestijn B, Corssmit EPM, et al · · 2024 · cited 3× · PMID 38368490 · DOI 10.1038/s41598-024-54718-1
Verify or expand the search:
- PubMed search for NCT06155734
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Fluorescence guided identification using indocyanine green
Trials testing the same drug.
- NCT07108855 — Detection of Upper Gastrointestinal Tumour Depth and Demarcation Using Systemic Administration of Indocyanine Green Duri · Phase 1, PHASE2 · recruiting
Other recruiting trials for Paraganglioma
Currently open trials in the same condition.
- NCT07195500 — Clinical Application of Somatostatin Receptor and Norepinephrine Transporter Targeted Imaging for Diagnosis and Staging · recruiting
- NCT06573723 — Institutional Registry of Rare Diseases · recruiting
- NCT06377033 — Using the EHR to Advance Genomic Medicine Across a Diverse Health System · NA · recruiting
- NCT06444607 — Hereditary Pheochromocytoma Assessment of Tumour Immunologies · recruiting
- NCT06440122 — The Incidence and Outcomes of Metabolically Active Brown Adipose Tissue (aBAT) in Patients With Pheochromocytoma or Para · recruiting
Other Leiden University Medical Center trials
Trials by the same sponsor.
- NCT07312565 — Occurrence of Abdominal Aortic Aneurysms in Patients With Aneurysmal Subarachnoid Hemorrhage · not yet recruiting
- NCT07090343 — Semaglutide in Patients Undergoing Transcatether Aortic Valve Replacement · Phase 3 · not yet recruiting
- NCT07498738 — Making Diabetes Care Fit for Young Adults Living With Type 1 Diabetes: Observations, Reflections and Expert Opinions · NA · not yet recruiting
- NCT06545292 — Microsampling for Therapeutic Drug Monitoring of Oral Oncolytics in Oncology Patients · NA · recruiting
- NCT07021495 — SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY) · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06155734 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Leiden University Medical Center
- Last refreshed: 4 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06155734.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing